Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Detection and Management of Cardiac Iron Overload in Sickle Cell Disease
NCT07023666Phase 2Recruiting
- Sponsor
- Inova Health System
- Start
- Oct 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferoxamine, deferasirox, deferiprone in sickle cell disease (SCD), sponsored by Inova Health System. Started Oct 2025; status: recruiting.
02
Drugs
deferoxaminedeferasiroxdeferiprone
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT07023666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07023666.